Comparison of 90-day morbidity and mortality between ileal conduit and orthotopic neobladder following radical cystectomy in a large multi-institutional database
In this multi-institutional cohort, patients with ONB had higher odds of perioperative complications; however, there was no difference in higher-severity complications between diversions.
Authors
- H Fekak
- Camilla Tajzler
- Girish S. Kulkarni (ORCID: https://orcid.org/0000-0002-6929-6124)
- Wassim Kassouf (ORCID: https://orcid.org/0000-0002-8350-0531)
- Rodney H. Breau (ORCID: https://orcid.org/0000-0003-2344-9022)
- Jonathan I. Izawa
- Ricardo Rendon (ORCID: https://orcid.org/0000-0002-4670-8384)
- Adrian Fairey
- Peter C. Black (ORCID: https://orcid.org/0000-0002-2919-7068)
- Michele Lodde (ORCID: https://orcid.org/0000-0001-8813-318X)
- Agnihotram V. Ramanakumar (ORCID: https://orcid.org/0000-0002-9803-7252)
- Claudio Jeldres (ORCID: https://orcid.org/0000-0003-4146-3100)
- Jean‐Baptiste Lattouf (ORCID: https://orcid.org/0000-0002-8192-0508)
- Jasmir G. Nayak (ORCID: https://orcid.org/0000-0002-1360-7798)
- Bobby Shayegan (ORCID: https://orcid.org/0000-0001-9570-610X)
- D. Robert Siemens (ORCID: https://orcid.org/0000-0002-3203-6468)
- Amir Eskandari (ORCID: https://orcid.org/0009-0007-1746-1136)
- Eric Hyndman
Institutions
- Western University (CA)
- Alberta Health Services (CA)
- Dalhousie University (CA)
- University Health Network (CA)
- Université de Sherbrooke (CA)
- University of British Columbia (CA)
- University of Ottawa (CA)
- University of Toronto (CA)
- Queen's University (CA)
- Ottawa Hospital (CA)
- McGill University Health Centre (CA)
- National Cancer Centre Japan (JP)
- Université Laval (CA)
- University of Manitoba (CA)
- McGill University (CA)
- Université de Montréal (CA)
- McMaster University (CA)
Publication Details
- Journal
- Canadian Urological Association Journal
- Published
- 2025-09-23
- DOI
- https://doi.org/10.5489/cuaj.9204
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- Bladder Cancer Canada
- Seagen
- EMD Serono